Cancer cells promote survival through depletion of the von Hippel-Lindau tumor suppressor by protein crosslinking.
- Published in:
- Oncogene, 2011, v. 30, n. 48, p. 4780, doi. 10.1038/onc.2011.183
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 2011 AND VI 30 AND IP 48
Results: 7
1
2
Hypoxia-driven cell motility reflects the interplay between JMY and HIF-1α.
- Published in:
- Oncogene, 2011, v. 30, n. 48, p. 4835, doi. 10.1038/onc.2011.188
- By:
- Publication type:
- Article
3
PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein.
- Published in:
- Oncogene, 2011, v. 30, n. 48, p. 4824, doi. 10.1038/onc.2011.190
- By:
- Publication type:
- Article
4
HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage.
- Published in:
- Oncogene, 2011, v. 30, n. 48, p. 4802, doi. 10.1038/onc.2011.182
- By:
- Publication type:
- Article
5
COP9 signalosome subunit 6 stabilizes COP1, which functions as an E3 ubiquitin ligase for 14-3-3σ.
- Published in:
- Oncogene, 2011, v. 30, n. 48, p. 4791, doi. 10.1038/onc.2011.192
- By:
- Publication type:
- Article
6
Conserved features of cancer cells define their sensitivity to HAMLET-induced death; c-Myc and glycolysis.
- Published in:
- Oncogene, 2011, v. 30, n. 48, p. 4765, doi. 10.1038/onc.2011.196
- By:
- Publication type:
- Article
7
Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma.
- Published in:
- Oncogene, 2011, v. 30, n. 48, p. 4814, doi. 10.1038/onc.2011.189
- By:
- Publication type:
- Article